Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease.
about
Obesity: "priming" the lung for injuryAdiponectin: an attractive marker for metabolic disorders in Chronic Obstructive Pulmonary Disease (COPD)Metabolic hormones, apolipoproteins, adipokines, and cytokines in the alveolar lining fluid of healthy adults: compartmentalization and physiological correlatesAdipokines in inflammation and metabolic diseaseNew insight into adiponectin role in obesity and obesity-related diseases.Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension.Pulmonary hypertension and metabolic syndrome: Possible connection, PPARĪ³ and Caveolin-1Impact of adiponectin deficiency on pulmonary responses to acute ozone exposure in mice.Pulmonary and cardiac function in asymptomatic obese subjects and changes following a structured weight reduction program: a prospective observational study.Metabolic and hormonal derangements in pulmonary hypertension: from mouse to man.Plasma Adiponectin, clinical factors, and patient outcomes during the acute respiratory distress syndrome.Cavin1; a regulator of lung function and macrophage phenotype.Obesity-related pulmonary arterial hypertension in rats correlates with increased circulating inflammatory cytokines and lipids and with oxidant damage in the arterial wall but not with hypoxiaUnrecognized glucose intolerance is common in pulmonary arterial hypertensionAdiponectin in cardiovascular inflammation and obesityAdiponectin decreases pulmonary arterial remodeling in murine models of pulmonary hypertension.Impaired right ventricular hemodynamics indicate preclinical pulmonary hypertension in patients with metabolic syndrome.Eosinophils are necessary for pulmonary arterial remodeling in a mouse model of eosinophilic inflammation-induced pulmonary hypertension.Adiponectin attenuates lipopolysaccharide-induced acute lung injury through suppression of endothelial cell activation.Pulmonary hypertension in obstructive sleep apnea: is it clinically significant? A critical analysis of the association and pathophysiology.Adiponectin and cardiovascular health: an updateObesity and pulmonary arterial hypertension: Is adiponectin the molecular link between these conditions?Adiponectin action: a combination of endocrine and autocrine/paracrine effects.Soluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasisC1q Deficiency Promotes Pulmonary Vascular Inflammation and Enhances the Susceptibility of the Lung Endothelium to Injury.Low Plasma Levels of Adiponectin Do Not Explain Acute Respiratory Distress Syndrome Risk: a Prospective Cohort Study of Patients with Severe Sepsis.Metabolic Dysfunction in Pulmonary Arterial Hypertension.Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension.Plasma adiponectin and mortality in critically ill subjects with acute respiratory failure.Scleroderma-related lung disease: are adipokines involved pathogenically?PPARgamma as a potential therapeutic target in pulmonary hypertension.PPARgamma activation: a potential treatment for pulmonary hypertension.Cellular and molecular aspects of vascular dysfunction in systemic sclerosis.Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease.A process-based review of mouse models of pulmonary hypertension.Experimental and transgenic models of pulmonary hypertension.Single Microfluidic Electrochemical Sensor System for Simultaneous Multi-Pulmonary Hypertension Biomarker Analyses.Vascular remodeling mediated by Angptl2 produced from perivascular adipose tissue.Hemodynamic improvement of pulmonary arterial hypertension after bariatric surgery: potential role for metabolic regulation.Adiponectin levels are elevated in patients with pulmonary arterial hypertension.
P2860
Q27012995-9D772F78-ADDA-4C9F-9153-C7BD7149E65FQ28390687-70E0C4AC-E0E1-4314-81AF-C28E46E95D84Q28545780-FBACE788-BE00-48B0-A1B9-CCA63D1AFDF2Q29620456-5A7CBA69-21FC-4909-8046-95CC80867BC6Q33943727-2A8AD0C9-9BBD-43A7-9E0E-0F2F5CC35DC5Q34118474-C774F4EB-ABC4-4759-9396-CB7B5818A1AEQ34178976-4360FD46-2D82-4AA1-AD14-DCC1BD68A37CQ34184850-149A7558-44CC-4670-B549-36717E0C82DCQ34214907-22F260D6-C581-48C6-99F2-3268107B083BQ34245617-3AD282F5-37B4-43BF-9137-78BA9244214DQ34258758-662A8F59-4C96-4B8D-8E6B-3AF83A4C9E30Q34698258-DF3D3312-1806-4767-904F-9FAC629C8C9BQ34782576-3390AB9B-2E22-4204-8C6E-465DEF5C5C59Q35085796-A0B36BBD-B149-44B6-8B94-A9FBBD65A556Q35219362-4D529E44-15FC-40EB-83B7-8E1E5890618DQ35219809-66E811B4-FF17-46D8-8E78-CBA3D6AE76A0Q35354138-847B2B19-8A05-45DC-92D8-14AE39745C5AQ35601475-9F7F554C-D6CF-4E36-BEE6-713C3BEB9659Q35658773-918C8309-81B2-449E-9181-547074DB0311Q35665717-16235EFF-51CC-46BA-89B2-9685E1B326AFQ35859734-2FA9DA81-64EB-4FFB-8029-CB28FF4B5997Q35896190-D41FC1C3-9409-4201-8D57-5EBF23825861Q35971216-6E71FA76-5797-46CE-B729-04C48EFEF178Q36074375-22C96109-9B84-43E7-9AD0-DAC2A06397DFQ36444135-D82AFB90-51EE-40E9-BD93-2D6FF8329E3BQ36694821-3D8FF070-70EC-4B4E-A68B-E08F06264DD5Q36825335-C56DF9BF-1F7C-476B-9301-284A05A542F0Q36888302-82206E99-F0FF-446F-A785-1B15BB9D3A16Q36989465-108772C4-99C9-4193-9FDD-3E2E7C21C0C8Q37408223-673A6D4C-CC07-488F-9F5C-A7B066FAB6E9Q37689190-A9B285E8-504F-4BC3-AB89-8699EF4D8483Q37725468-DA144FE0-32FF-40CF-84C2-574C2802AB0EQ37768336-E33E4015-4FB3-4626-9D6E-858257D15388Q37972596-4A01EFDD-ED83-44CD-A166-2ABFB7C31273Q38078369-90518022-7010-4FB3-80ED-323368E13F9AQ38112056-9ED61D3F-C274-4F08-93BA-A3B77305433CQ41308651-BE245B18-1703-45C9-AA55-92F72DA3099CQ42730442-CF90AD2D-89B5-47F7-9E79-3CF29F3FC025Q43242175-0D244FFB-423E-4C8C-B96C-598BA441B3DAQ44876073-C1D22F2C-9693-4FF8-AD54-87B68F55217D
P2860
Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease.
description
article cientĆfic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo cientĆfico
@pt
bilimsel makale
@tr
scientific article published on 26 June 2009
@en
vedeckĆ½ ÄlĆ”nok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vÄdeckĆ½ ÄlĆ”nek
@cs
name
Adiponectin deficiency: a mode ...... th pulmonary vascular disease.
@en
Adiponectin deficiency: a mode ...... th pulmonary vascular disease.
@nl
type
label
Adiponectin deficiency: a mode ...... th pulmonary vascular disease.
@en
Adiponectin deficiency: a mode ...... th pulmonary vascular disease.
@nl
prefLabel
Adiponectin deficiency: a mode ...... th pulmonary vascular disease.
@en
Adiponectin deficiency: a mode ...... th pulmonary vascular disease.
@nl
P2093
P2860
P1476
Adiponectin deficiency: a mode ...... ith pulmonary vascular disease
@en
P2093
Christopher A Fiack
Daniel Dwyer
Kaori Sato
Kenneth Walsh
Noriyuki Ouchi
Ross Summer
Yasumasa Ikeda
P2860
P304
P356
10.1152/AJPLUNG.90599.2008
P577
2009-06-26T00:00:00Z